Crossref journal-article
SAGE Publications
Antiviral Chemistry and Chemotherapy (179)
Abstract

LY217896 (1,3,4-thiadiazol-2-ylcyanamide) is a 2-substituted thiadiazole that is an effective inhibitor of influenza A and B viruses in vitro and in the mouse infection model. The in vitro anti-influenza activity of LY217896 is reversed by a 10-fold excess amount of guanine or guanosine. LY217896 (1 or 10μg ml−1) effected a selective 60% decrease in the levels of intracellular pools of GTP in MDCK cells. The extent of cytotoxicity of LY217896 is positively correlated with the amount of LY217896 metabolite formed intracellularly. A cell line, derived from parental MDCK cells, was selected for resistance to 50 ng of LY217896 per ml. Unlike parental MDCK cells, the resistant cells were able to undergo log phase replication in LY217896 (25 g ml−1) and were unable to metabolize the compound. Furthermore, LY217896 had no antiviral activity against influenza A/Ann Arbor (IC50>200μg ml−1) or vaccinia virus (IC50= 13 μg ml−1) in resistant cells. In contrast, LY217896 inhibited influenza A/Ann Arbor (IC50= 0.5 μg ml−1) or vaccinia virus (IC50= 0.13 μg ml−1) in the parental MDCK cells. A thiadiazole, with a guanidinyl group in the 2 position, and ribavirin were active in both the parental cells and resistant cells. Nicotinamide (up to 240-fold excess) did not reverse the anti-influenza activity of LY217896 in vitro or in the mouse infection model. A 10-fold excess of nicotinamide reversed the cytotoxicity of 2-aminothiadiazole but not that of LY217896.

Bibliography

Colacino, J. M., Birch, G. M., & Tang, J. C. (1993). Cellular Metabolism and Anti-Influenza Activity of 1,3,4-Thiadiazol-2-Ylcyanamide (LY217896). Antiviral Chemistry and Chemotherapy, 4(5), 271–280.

Authors 3
  1. J. M. Colacino (first)
  2. G. M. Birch (additional)
  3. J. C. Tang (additional)
References 41 Referenced 7
  1. 10.1093/infdis/159.3.430
  2. {'key': 'bibr2-095632029300400503', 'first-page': '1195', 'volume': '20', 'author': 'Ciotti M.M.', 'year': '1960', 'journal-title': 'Cancer Res'} / Cancer Res by Ciotti M.M. (1960)
  3. 10.1093/infdis/133.Supplement_2.A114
  4. 10.1128/AAC.34.11.2156
  5. 10.1056/NEJM198209023071002
  6. 10.1016/S0090-9556(25)07321-0 / Drug Metab Disp by Ehlhardt W.J. (1993)
  7. 10.1016/0042-6822(65)90273-4
  8. 10.1542/peds.80.2.275
  9. 10.1128/AAC.17.5.865
  10. 10.1056/NEJM198912213212502
  11. 10.1016/0166-3542(90)90063-D
  12. 10.1128/AAC.3.2.235
  13. {'key': 'bibr13-095632029300400503', 'first-page': '703', 'volume-title': 'Antimicrobial agents and chemotherapy.', 'author': 'Jackson G.G.', 'year': '1963'} / Antimicrobial agents and chemotherapy. by Jackson G.G. (1963)
  14. 10.1016/S0140-6736(81)91152-1
  15. 10.1002/art.1780080447
  16. 10.1038/1841805b0
  17. 10.1016/0042-6822(63)90066-7
  18. 10.1128/AAC.12.4.498
  19. 10.1016/0042-6822(81)90060-X
  20. 10.1001/jama.1983.03330430047028
  21. {'key': 'bibr21-095632029300400503', 'first-page': '542', 'volume': '110', 'author': 'Mostow S.R.', 'year': '1974', 'journal-title': 'Am Rev Respir Dis'} / Am Rev Respir Dis by Mostow S.R. (1974)
  22. 10.1016/0006-2952(77)90246-5
  23. {'key': 'bibr23-095632029300400503', 'first-page': '182', 'volume': '37', 'author': 'Nelson J.A.', 'year': '1977', 'journal-title': 'Cancer Res'} / Cancer Res by Nelson J.A. (1977)
  24. {'key': 'bibr24-095632029300400503', 'first-page': '1375', 'volume': '36', 'author': 'Nelson J.A.', 'year': '1976', 'journal-title': 'Cancer Res'} / Cancer Res by Nelson J.A. (1976)
  25. 10.1099/0022-1317-28-3-409
  26. 10.1021/jm00344a002
  27. {'key': 'bibr27-095632029300400503', 'first-page': '257', 'volume': '30', 'author': 'Scott W.J.', 'year': '1973', 'journal-title': 'J Embryol Exp Morph'} / J Embryol Exp Morph by Scott W.J. (1973)
  28. {'key': 'bibr28-095632029300400503', 'first-page': '4827', 'volume': '48', 'author': 'Scudiero D.A.', 'year': '1988', 'journal-title': 'Cancer Res'} / Cancer Res by Scudiero D.A. (1988)
  29. 10.1351/pac198557030423
  30. 10.1016/0006-2952(59)90053-X
  31. 10.1126/science.177.4050.705
  32. 10.1093/infdis/141.5.548
  33. 10.1128/AAC.31.8.1285
  34. 10.1111/j.1749-6632.1977.tb21952.x
  35. 10.1073/pnas.70.4.1174
  36. 10.1093/infdis/133.Supplement_2.A109
  37. 10.1002/jlcr.2580310702
  38. 10.1021/jm00281a014
  39. 10.1021/jm00109a001
  40. 10.1016/0166-3542(85)90012-9
  41. 10.1016/0166-3542(90)90005-R
Dates
Type When
Created 10 years, 3 months ago (May 8, 2015, 6:10 p.m.)
Deposited 3 months ago (May 27, 2025, 5:31 p.m.)
Indexed 3 months ago (May 27, 2025, 6:10 p.m.)
Issued 31 years, 10 months ago (Oct. 1, 1993)
Published 31 years, 10 months ago (Oct. 1, 1993)
Published Online 31 years, 10 months ago (Oct. 1, 1993)
Published Print 31 years, 10 months ago (Oct. 1, 1993)
Funders 0

None

@article{Colacino_1993, title={Cellular Metabolism and Anti-Influenza Activity of 1,3,4-Thiadiazol-2-Ylcyanamide (LY217896)}, volume={4}, ISSN={2040-2066}, url={http://dx.doi.org/10.1177/095632029300400503}, DOI={10.1177/095632029300400503}, number={5}, journal={Antiviral Chemistry and Chemotherapy}, publisher={SAGE Publications}, author={Colacino, J. M. and Birch, G. M. and Tang, J. C.}, year={1993}, month=oct, pages={271–280} }